Industry Research Reports
Home > Reports > Chemical & Material > Global Phenylephrine API Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Phenylephrine API Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-22
Pages: 176 Pages
Report ld: 5198126
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Phenylephrine API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Phenylephrine is a decongestant that is used to treat stuffy nose and sinus congestion caused by the common cold, hay fever, or other allergies. Phenylephrine may also be used for purposes not listed in this medication guide.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Phenylephrine API market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Transo-Pharm
- Malladi Drugs & Pharmaceuticals
- Beloorbayir Biotech
- Bazayan & Co
- Hygro Chemicals
- INDOCO REMEDIES
- Iwaki Seiyaku
- Kimia BioSciences
- Nishchem International
- Qualitek Pharma
- Shenzhen Oriental Pharmaceutial
- Unichem Laboratories
- Titan Laboratories
- Synergene
- Spansules Pharma
- JSN Chemicals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity 10%
- Purity 20%
- Purity 40%
- Purity 60%
Segment by Application
- Pharmaceutical Industry
- Research Organization
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Phenylephrine API study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Phenylephrine API: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Phenylephrine API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity 10%
1.2.3 Purity 20%
1.2.4 Purity 40%
1.2.5 Purity 60%
1.3 Market Segmentation by Application
1.3.1 Global Phenylephrine API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Industry
1.3.3 Research Organization
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Phenylephrine API Revenue Estimates and Forecasts 2020-2031
2.2 Global Phenylephrine API Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Phenylephrine API Sales Estimates and Forecasts 2020-2031
2.4 Global Phenylephrine API Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Phenylephrine API Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Phenylephrine API Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Phenylephrine API Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity 10% Market Size by Manufacturers
4.5.2 Purity 20% Market Size by Manufacturers
4.5.3 Purity 40% Market Size by Manufacturers
4.5.4 Purity 60% Market Size by Manufacturers
4.6 Global Phenylephrine API Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Phenylephrine API Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Phenylephrine API Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Phenylephrine API Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Phenylephrine API Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Phenylephrine API Sales and Revenue by Type (2020-2031)
7.4 North America Phenylephrine API Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Phenylephrine API Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Phenylephrine API Sales and Revenue by Type (2020-2031)
8.4 Europe Phenylephrine API Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Phenylephrine API Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Phenylephrine API Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Phenylephrine API Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Phenylephrine API Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Phenylephrine API Sales and Revenue by Type (2020-2031)
10.4 Central and South America Phenylephrine API Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Phenylephrine API Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Phenylephrine API Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Phenylephrine API Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Phenylephrine API Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Transo-Pharm
12.1.1 Transo-Pharm Corporation Information
12.1.2 Transo-Pharm Business Overview
12.1.3 Transo-Pharm Phenylephrine API Product Models, Descriptions and Specifications
12.1.4 Transo-Pharm Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Transo-Pharm Phenylephrine API Sales by Product in 2024
12.1.6 Transo-Pharm Phenylephrine API Sales by Application in 2024
12.1.7 Transo-Pharm Phenylephrine API Sales by Geographic Area in 2024
12.1.8 Transo-Pharm Phenylephrine API SWOT Analysis
12.1.9 Transo-Pharm Recent Developments
12.2 Malladi Drugs & Pharmaceuticals
12.2.1 Malladi Drugs & Pharmaceuticals Corporation Information
12.2.2 Malladi Drugs & Pharmaceuticals Business Overview
12.2.3 Malladi Drugs & Pharmaceuticals Phenylephrine API Product Models, Descriptions and Specifications
12.2.4 Malladi Drugs & Pharmaceuticals Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Malladi Drugs & Pharmaceuticals Phenylephrine API Sales by Product in 2024
12.2.6 Malladi Drugs & Pharmaceuticals Phenylephrine API Sales by Application in 2024
12.2.7 Malladi Drugs & Pharmaceuticals Phenylephrine API Sales by Geographic Area in 2024
12.2.8 Malladi Drugs & Pharmaceuticals Phenylephrine API SWOT Analysis
12.2.9 Malladi Drugs & Pharmaceuticals Recent Developments
12.3 Beloorbayir Biotech
12.3.1 Beloorbayir Biotech Corporation Information
12.3.2 Beloorbayir Biotech Business Overview
12.3.3 Beloorbayir Biotech Phenylephrine API Product Models, Descriptions and Specifications
12.3.4 Beloorbayir Biotech Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Beloorbayir Biotech Phenylephrine API Sales by Product in 2024
12.3.6 Beloorbayir Biotech Phenylephrine API Sales by Application in 2024
12.3.7 Beloorbayir Biotech Phenylephrine API Sales by Geographic Area in 2024
12.3.8 Beloorbayir Biotech Phenylephrine API SWOT Analysis
12.3.9 Beloorbayir Biotech Recent Developments
12.4 Bazayan & Co
12.4.1 Bazayan & Co Corporation Information
12.4.2 Bazayan & Co Business Overview
12.4.3 Bazayan & Co Phenylephrine API Product Models, Descriptions and Specifications
12.4.4 Bazayan & Co Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Bazayan & Co Phenylephrine API Sales by Product in 2024
12.4.6 Bazayan & Co Phenylephrine API Sales by Application in 2024
12.4.7 Bazayan & Co Phenylephrine API Sales by Geographic Area in 2024
12.4.8 Bazayan & Co Phenylephrine API SWOT Analysis
12.4.9 Bazayan & Co Recent Developments
12.5 Hygro Chemicals
12.5.1 Hygro Chemicals Corporation Information
12.5.2 Hygro Chemicals Business Overview
12.5.3 Hygro Chemicals Phenylephrine API Product Models, Descriptions and Specifications
12.5.4 Hygro Chemicals Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Hygro Chemicals Phenylephrine API Sales by Product in 2024
12.5.6 Hygro Chemicals Phenylephrine API Sales by Application in 2024
12.5.7 Hygro Chemicals Phenylephrine API Sales by Geographic Area in 2024
12.5.8 Hygro Chemicals Phenylephrine API SWOT Analysis
12.5.9 Hygro Chemicals Recent Developments
12.6 INDOCO REMEDIES
12.6.1 INDOCO REMEDIES Corporation Information
12.6.2 INDOCO REMEDIES Business Overview
12.6.3 INDOCO REMEDIES Phenylephrine API Product Models, Descriptions and Specifications
12.6.4 INDOCO REMEDIES Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 INDOCO REMEDIES Recent Developments
12.7 Iwaki Seiyaku
12.7.1 Iwaki Seiyaku Corporation Information
12.7.2 Iwaki Seiyaku Business Overview
12.7.3 Iwaki Seiyaku Phenylephrine API Product Models, Descriptions and Specifications
12.7.4 Iwaki Seiyaku Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Iwaki Seiyaku Recent Developments
12.8 Kimia BioSciences
12.8.1 Kimia BioSciences Corporation Information
12.8.2 Kimia BioSciences Business Overview
12.8.3 Kimia BioSciences Phenylephrine API Product Models, Descriptions and Specifications
12.8.4 Kimia BioSciences Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Kimia BioSciences Recent Developments
12.9 Nishchem International
12.9.1 Nishchem International Corporation Information
12.9.2 Nishchem International Business Overview
12.9.3 Nishchem International Phenylephrine API Product Models, Descriptions and Specifications
12.9.4 Nishchem International Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Nishchem International Recent Developments
12.10 Qualitek Pharma
12.10.1 Qualitek Pharma Corporation Information
12.10.2 Qualitek Pharma Business Overview
12.10.3 Qualitek Pharma Phenylephrine API Product Models, Descriptions and Specifications
12.10.4 Qualitek Pharma Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Qualitek Pharma Recent Developments
12.11 Shenzhen Oriental Pharmaceutial
12.11.1 Shenzhen Oriental Pharmaceutial Corporation Information
12.11.2 Shenzhen Oriental Pharmaceutial Business Overview
12.11.3 Shenzhen Oriental Pharmaceutial Phenylephrine API Product Models, Descriptions and Specifications
12.11.4 Shenzhen Oriental Pharmaceutial Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Shenzhen Oriental Pharmaceutial Recent Developments
12.12 Unichem Laboratories
12.12.1 Unichem Laboratories Corporation Information
12.12.2 Unichem Laboratories Business Overview
12.12.3 Unichem Laboratories Phenylephrine API Product Models, Descriptions and Specifications
12.12.4 Unichem Laboratories Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Unichem Laboratories Recent Developments
12.13 Titan Laboratories
12.13.1 Titan Laboratories Corporation Information
12.13.2 Titan Laboratories Business Overview
12.13.3 Titan Laboratories Phenylephrine API Product Models, Descriptions and Specifications
12.13.4 Titan Laboratories Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Titan Laboratories Recent Developments
12.14 Synergene
12.14.1 Synergene Corporation Information
12.14.2 Synergene Business Overview
12.14.3 Synergene Phenylephrine API Product Models, Descriptions and Specifications
12.14.4 Synergene Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 Synergene Recent Developments
12.15 Spansules Pharma
12.15.1 Spansules Pharma Corporation Information
12.15.2 Spansules Pharma Business Overview
12.15.3 Spansules Pharma Phenylephrine API Product Models, Descriptions and Specifications
12.15.4 Spansules Pharma Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 Spansules Pharma Recent Developments
12.16 JSN Chemicals
12.16.1 JSN Chemicals Corporation Information
12.16.2 JSN Chemicals Business Overview
12.16.3 JSN Chemicals Phenylephrine API Product Models, Descriptions and Specifications
12.16.4 JSN Chemicals Phenylephrine API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 JSN Chemicals Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Phenylephrine API Industry Chain
13.2 Phenylephrine API Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Phenylephrine API Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Phenylephrine API Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Phenylephrine API Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Phenylephrine API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Phenylephrine API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Phenylephrine API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Phenylephrine API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Phenylephrine API Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Phenylephrine API Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Phenylephrine API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Phenylephrine API Sales by Region (2020-2025) & (Tons)
Table 8. Global Phenylephrine API Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Phenylephrine API Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Phenylephrine API Production by Region (2020-2025) & (Tons)
Table 12. Global Phenylephrine API Production by Region (2026-2031) & (Tons)
Table 13. Global Phenylephrine API Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Phenylephrine API Sales Share by Manufacturers (2020-2025)
Table 15. Global Phenylephrine API Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Phenylephrine API Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Phenylephrine API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylephrine API as of 2024)
Table 19. Global Phenylephrine API Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Phenylephrine API Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Phenylephrine API Manufacturing Base and Headquarters
Table 22. Global Phenylephrine API Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Phenylephrine API Sales by Type (2020-2025) & (Tons)
Table 26. Global Phenylephrine API Sales by Type (2026-2031) & (Tons)
Table 27. Global Phenylephrine API Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Phenylephrine API Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Phenylephrine API ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Phenylephrine API Sales by Application (2020-2025) & (Tons)
Table 32. Global Phenylephrine API Sales by Application (2026-2031) & (Tons)
Table 33. Phenylephrine API High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Phenylephrine API Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Phenylephrine API Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Phenylephrine API ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Phenylephrine API Growth Accelerators and Market Barriers
Table 40. North America Phenylephrine API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Phenylephrine API Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Phenylephrine API Growth Accelerators and Market Barriers
Table 43. Europe Phenylephrine API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Phenylephrine API Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Phenylephrine API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Phenylephrine API Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Phenylephrine API Growth Accelerators and Market Barriers
Table 48. Southeast Asia Phenylephrine API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Phenylephrine API Investment Opportunities and Key Challenges
Table 50. Central and South America Phenylephrine API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Phenylephrine API Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Phenylephrine API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Transo-Pharm Corporation Information
Table 54. Transo-Pharm Description and Major Businesses
Table 55. Transo-Pharm Product Models, Descriptions and Specifications
Table 56. Transo-Pharm Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Transo-Pharm Sales Value Proportion by Product in 2024
Table 58. Transo-Pharm Sales Value Proportion by Application in 2024
Table 59. Transo-Pharm Sales Value Proportion by Geographic Area in 2024
Table 60. Transo-Pharm Phenylephrine API SWOT Analysis
Table 61. Transo-Pharm Recent Developments
Table 62. Malladi Drugs & Pharmaceuticals Corporation Information
Table 63. Malladi Drugs & Pharmaceuticals Description and Major Businesses
Table 64. Malladi Drugs & Pharmaceuticals Product Models, Descriptions and Specifications
Table 65. Malladi Drugs & Pharmaceuticals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Malladi Drugs & Pharmaceuticals Sales Value Proportion by Product in 2024
Table 67. Malladi Drugs & Pharmaceuticals Sales Value Proportion by Application in 2024
Table 68. Malladi Drugs & Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 69. Malladi Drugs & Pharmaceuticals Phenylephrine API SWOT Analysis
Table 70. Malladi Drugs & Pharmaceuticals Recent Developments
Table 71. Beloorbayir Biotech Corporation Information
Table 72. Beloorbayir Biotech Description and Major Businesses
Table 73. Beloorbayir Biotech Product Models, Descriptions and Specifications
Table 74. Beloorbayir Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Beloorbayir Biotech Sales Value Proportion by Product in 2024
Table 76. Beloorbayir Biotech Sales Value Proportion by Application in 2024
Table 77. Beloorbayir Biotech Sales Value Proportion by Geographic Area in 2024
Table 78. Beloorbayir Biotech Phenylephrine API SWOT Analysis
Table 79. Beloorbayir Biotech Recent Developments
Table 80. Bazayan & Co Corporation Information
Table 81. Bazayan & Co Description and Major Businesses
Table 82. Bazayan & Co Product Models, Descriptions and Specifications
Table 83. Bazayan & Co Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Bazayan & Co Sales Value Proportion by Product in 2024
Table 85. Bazayan & Co Sales Value Proportion by Application in 2024
Table 86. Bazayan & Co Sales Value Proportion by Geographic Area in 2024
Table 87. Bazayan & Co Phenylephrine API SWOT Analysis
Table 88. Bazayan & Co Recent Developments
Table 89. Hygro Chemicals Corporation Information
Table 90. Hygro Chemicals Description and Major Businesses
Table 91. Hygro Chemicals Product Models, Descriptions and Specifications
Table 92. Hygro Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Hygro Chemicals Sales Value Proportion by Product in 2024
Table 94. Hygro Chemicals Sales Value Proportion by Application in 2024
Table 95. Hygro Chemicals Sales Value Proportion by Geographic Area in 2024
Table 96. Hygro Chemicals Phenylephrine API SWOT Analysis
Table 97. Hygro Chemicals Recent Developments
Table 98. INDOCO REMEDIES Corporation Information
Table 99. INDOCO REMEDIES Description and Major Businesses
Table 100. INDOCO REMEDIES Product Models, Descriptions and Specifications
Table 101. INDOCO REMEDIES Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. INDOCO REMEDIES Recent Developments
Table 103. Iwaki Seiyaku Corporation Information
Table 104. Iwaki Seiyaku Description and Major Businesses
Table 105. Iwaki Seiyaku Product Models, Descriptions and Specifications
Table 106. Iwaki Seiyaku Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Iwaki Seiyaku Recent Developments
Table 108. Kimia BioSciences Corporation Information
Table 109. Kimia BioSciences Description and Major Businesses
Table 110. Kimia BioSciences Product Models, Descriptions and Specifications
Table 111. Kimia BioSciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Kimia BioSciences Recent Developments
Table 113. Nishchem International Corporation Information
Table 114. Nishchem International Description and Major Businesses
Table 115. Nishchem International Product Models, Descriptions and Specifications
Table 116. Nishchem International Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Nishchem International Recent Developments
Table 118. Qualitek Pharma Corporation Information
Table 119. Qualitek Pharma Description and Major Businesses
Table 120. Qualitek Pharma Product Models, Descriptions and Specifications
Table 121. Qualitek Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Qualitek Pharma Recent Developments
Table 123. Shenzhen Oriental Pharmaceutial Corporation Information
Table 124. Shenzhen Oriental Pharmaceutial Description and Major Businesses
Table 125. Shenzhen Oriental Pharmaceutial Product Models, Descriptions and Specifications
Table 126. Shenzhen Oriental Pharmaceutial Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. Shenzhen Oriental Pharmaceutial Recent Developments
Table 128. Unichem Laboratories Corporation Information
Table 129. Unichem Laboratories Description and Major Businesses
Table 130. Unichem Laboratories Product Models, Descriptions and Specifications
Table 131. Unichem Laboratories Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 132. Unichem Laboratories Recent Developments
Table 133. Titan Laboratories Corporation Information
Table 134. Titan Laboratories Description and Major Businesses
Table 135. Titan Laboratories Product Models, Descriptions and Specifications
Table 136. Titan Laboratories Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 137. Titan Laboratories Recent Developments
Table 138. Synergene Corporation Information
Table 139. Synergene Description and Major Businesses
Table 140. Synergene Product Models, Descriptions and Specifications
Table 141. Synergene Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 142. Synergene Recent Developments
Table 143. Spansules Pharma Corporation Information
Table 144. Spansules Pharma Description and Major Businesses
Table 145. Spansules Pharma Product Models, Descriptions and Specifications
Table 146. Spansules Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 147. Spansules Pharma Recent Developments
Table 148. JSN Chemicals Corporation Information
Table 149. JSN Chemicals Description and Major Businesses
Table 150. JSN Chemicals Product Models, Descriptions and Specifications
Table 151. JSN Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 152. JSN Chemicals Recent Developments
Table 153. Key Raw Materials Distribution
Table 154. Raw Materials Key Suppliers
Table 155. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 156. Milestones in Production Technology Evolution
Table 157. Distributors List
Table 158. Market Trends and Market Evolution
Table 159. Market Drivers and Opportunities
Table 160. Market Challenges, Risks, and Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Phenylephrine API Product Picture
Figure 2. Global Phenylephrine API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity 10% Product Picture
Figure 4. Purity 20% Product Picture
Figure 5. Purity 40% Product Picture
Figure 6. Purity 60% Product Picture
Figure 7. Global Phenylephrine API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Pharmaceutical Industry
Figure 9. Research Organization
Figure 10. Others
Figure 11. Phenylephrine API Report Years Considered
Figure 12. Global Phenylephrine API Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 14. Global Phenylephrine API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Phenylephrine API Revenue Market Share by Region (2020-2031)
Figure 16. Global Phenylephrine API Sales (2020-2031) & (Tons)
Figure 17. Global Phenylephrine API Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Phenylephrine API Sales Market Share by Region (2020-2031)
Figure 19. Global Phenylephrine API Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 20. Global Phenylephrine API Production Trend by Region (2020-2031) (Tons)
Figure 21. Global Phenylephrine API Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Phenylephrine API Production Growth Rate in North America (2020-2031) & (Tons)
Figure 24. Phenylephrine API Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 25. Phenylephrine API Production Growth Rate in China (2020-2031) & (Tons)
Figure 26. Phenylephrine API Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 27. Top 5 and Top 10 Manufacturers Phenylephrine API Sales Volume Market Share in 2024
Figure 28. Global Phenylephrine API Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. Purity 10% Revenue Market Share by Manufacturer in 2024
Figure 31. Purity 20% Revenue Market Share by Manufacturer in 2024
Figure 32. Purity 40% Revenue Market Share by Manufacturer in 2024
Figure 33. Purity 60% Revenue Market Share by Manufacturer in 2024
Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 36. Global Phenylephrine API Sales Market Share by Type (2020-2031)
Figure 37. Global Phenylephrine API Revenue Market Share by Type (2020-2031)
Figure 38. Global Phenylephrine API Sales Market Share by Application (2020-2031)
Figure 39. Global Phenylephrine API Revenue Market Share by Application (2020-2031)
Figure 40. North America Phenylephrine API Sales YoY (2020-2031) & (Tons)
Figure 41. North America Phenylephrine API Revenue YoY (2020-2031) & (US$ Million)
Figure 42. North America Top 5 Manufacturers Phenylephrine API Sales Revenue (US$ Million) in 2024
Figure 43. North America Phenylephrine API Sales Volume (Tons) by Type (2020- 2031)
Figure 44. North America Phenylephrine API Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 45. North America Phenylephrine API Sales Volume (Tons) by Application (2020-2031)
Figure 46. North America Phenylephrine API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. US Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 48. Canada Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 49. Mexico Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 50. Europe Phenylephrine API Sales YoY (2020-2031) & (Tons)
Figure 51. Europe Phenylephrine API Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Europe Top 5 Manufacturers Phenylephrine API Sales Revenue (US$ Million) in 2024
Figure 53. Europe Phenylephrine API Sales Volume (Tons) by Type (2020-2031)
Figure 54. Europe Phenylephrine API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 55. Europe Phenylephrine API Sales Volume (Tons) by Application (2020-2031)
Figure 56. Europe Phenylephrine API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Germany Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 58. France Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 59. U.K. Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 60. Italy Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 61. Russia Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Phenylephrine API Sales YoY (2020-2031) & (Tons)
Figure 63. Asia-Pacific Phenylephrine API Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Top 8 Manufacturers Phenylephrine API Sales Revenue (US$ Million) in 2024
Figure 65. Asia-Pacific Phenylephrine API Sales Volume (Tons) by Type (2020- 2031)
Figure 66. Asia-Pacific Phenylephrine API Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 67. Asia-Pacific Phenylephrine API Sales Volume (Tons) by Application (2020-2031)
Figure 68. Asia-Pacific Phenylephrine API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Indonesia Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 70. Japan Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 71. South Korea Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 72. China Taiwan Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 73. India Phenylephrine API Revenue (2020-2031) & (US$ Million)
Figure 74. Central and South America Phenylephrine API Sales YoY (2020-2031) & (Tons)
Figure 75. Central and South America Phenylephrine API Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Central and South America Top 5 Manufacturers Phenylephrine API Sales Revenue (US$ Million) in 2024
Figure 77. Central and South America Phenylephrine API Sales Volume (Tons) by Type (2021-2031)
Figure 78. Central and South America Phenylephrine API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Central and South America Phenylephrine API Sales Volume (Tons) by Application (2020-2031)
Figure 80. Central and South America Phenylephrine API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. Brazil Phenylephrine API Revenue (2020-2025) & (US$ Million)
Figure 82. Argentina Phenylephrine API Revenue (2020-2025) & (US$ Million)
Figure 83. Middle East, and Africa Phenylephrine API Sales YoY (2020-2031) & (Tons)
Figure 84. Middle East and Africa Phenylephrine API Revenue YoY (2020-2031) & (US$ Million)
Figure 85. Middle East and Africa Top 5 Manufacturers Phenylephrine API Sales Revenue (US$ Million) in 2024
Figure 86. Middle East and Africa Phenylephrine API Sales Volume (Tons) by Type (2021-2031)
Figure 87. South America Phenylephrine API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 88. Middle East and Africa Phenylephrine API Sales Volume (Tons) by Application (2020-2031)
Figure 89. Middle East and Africa Phenylephrine API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 90. GCC Countries Phenylephrine API Revenue (2020-2025) & (US$ Million)
Figure 91. Turkey Phenylephrine API Revenue (2020-2025) & (US$ Million)
Figure 92. Egypt Phenylephrine API Revenue (2020-2025) & (US$ Million)
Figure 93. South Africa Phenylephrine API Revenue (2020-2025) & (US$ Million)
Figure 94. Phenylephrine API Industry Chain Mapping
Figure 95. Regional Phenylephrine API Manufacturing Base Distribution (%)
Figure 96. Phenylephrine API Production Process
Figure 97. Regional Phenylephrine API Production Cost Structure
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Phenylephrine API market?
The top companies in the global Phenylephrine API market are Transo-Pharm、Malladi Drugs & Pharmaceuticals、Beloorbayir Biotech.
Related Reports
Phenylephrine API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Phenylephrine API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 146
USD 3950.00
(Single User License)
Global Phenylephrine API Market Research Report 2026
The global Phenylephrine API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 153
USD 2900.00
(Single User License)
Phenylephrine API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Phenylephrine API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 136
USD 3950.00
(Single User License)
Global Phenylephrine API Market Research Report 2025
The global market for Phenylephrine API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 115
USD 2900.00
(Single User License)
Global Phenylephrine API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Phenylephrine API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 108
USD 4250.00
(Single User License)
Global Phenylephrine API Market Insights, Forecast to 2030
Phenylephrine is a decongestant that is used to treat stuffy nose and sinus congestion caused by the common cold, hay fever, or other allergies. Phenylephrine may also be used for purposes not listed in this medication guide.
Published Date: 2024-04-07
Pages: 115
USD 4900.00
(Single User License)
Phenylephrine API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Phenylephrine is a decongestant that is used to treat stuffy nose and sinus congestion caused by the common cold, hay fever, or other allergies. Phenylephrine may also be used for purposes not listed in this medication guide.
Published Date: 2024-02-19
Pages: 139
USD 3950.00
(Single User License)
Global Phenylephrine API Market Research Report 2024
Phenylephrine is a decongestant that is used to treat stuffy nose and sinus congestion caused by the common cold, hay fever, or other allergies. Phenylephrine may also be used for purposes not listed in this medication guide.
Published Date: 2024-01-11
Pages: 113
USD 2900.00
(Single User License)
Phenylephrine API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Phenylephrine API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 146
USD 3950.00 (Single User License)Global Phenylephrine API Market Research Report 2026
The global Phenylephrine API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 153
USD 2900.00 (Single User License)Phenylephrine API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Phenylephrine API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 136
USD 3950.00 (Single User License)Global Phenylephrine API Market Research Report 2025
The global market for Phenylephrine API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 115
USD 2900.00 (Single User License)Global Phenylephrine API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Phenylephrine API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 108
USD 4250.00 (Single User License)Global Phenylephrine API Market Insights, Forecast to 2030
Phenylephrine is a decongestant that is used to treat stuffy nose and sinus congestion caused by the common cold, hay fever, or other allergies. Phenylephrine may also be used for purposes not listed in this medication guide.
Published: 2024-04-07
Pages: 115
USD 4900.00 (Single User License)Phenylephrine API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Phenylephrine is a decongestant that is used to treat stuffy nose and sinus congestion caused by the common cold, hay fever, or other allergies. Phenylephrine may also be used for purposes not listed in this medication guide.
Published: 2024-02-19
Pages: 139
USD 3950.00 (Single User License)Global Phenylephrine API Market Research Report 2024
Phenylephrine is a decongestant that is used to treat stuffy nose and sinus congestion caused by the common cold, hay fever, or other allergies. Phenylephrine may also be used for purposes not listed in this medication guide.
Published: 2024-01-11
Pages: 113
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now